Importantly, the negative impact of high CD163+ TAM infiltration on the PFS was still observed when the analysis was focused on non‐triple negative BC (TNBC) patients (n = 207 patients; log‐rank P‐value = 0.0022). Here, CD163 is linked to breast cancer.